NThe strength of this study is eradicating selection bias by enrolling all patients with new onset IBD. It utilized
NThe strength of this study is eradicating selection bias by enrolling all patients with new onset IBD. It utilized a nationally representative sample size of 23,982 biopsied and confirmed cases with a predictive value of 95%. The limitation of the study is the assumption that all prescribed and dispensed medications through the Prescribe Drug Register […]